Sign In
Get Clay Free →

Suggestions

    Charlie Petty

    Partner at Global Health Investment Corporation

    Charlie Petty is a prominent technology venture capital investor with a focus on human and environmental health.

    His career highlights include involvement with companies like Excision Biotherapeutics, Minervax, Vitrivax, ChromaCode, Codagenix, and Alydia Health (acquired by Merck).

    Charlie Petty's educational background is diverse, having studied at various institutions such as Virginia Tech, Dartmouth's Tuck School of Business, and Elon University.

    He holds degrees in Bachelor of Arts, Legal Studies, Political Science, Law, Government, Economics, and Journalism.

    Charlie Petty is the Co-Founder and Principal at Adjuvant Capital, and has held various positions in organizations like Excision Biotherapeutics and Vitrivax.

    He has also been involved in boards, directorial roles, and investment positions in companies like Minervax, Seraphina Therapeutics, and Codagenix.

    Additionally, Charlie has experience as an Investment Professional at the Global Health Investment Fund and as an Associate at Artemis Capital Partners.

    His background includes roles as a Research Consultant at Encite Capital, an Analyst at Fannie Mae, and a Financial Analyst at Sèvis Finansye Fonkoze.

    Charlie Petty's wide-ranging expertise and experience positions him as a leading figure in the venture capital and health technology sectors.

    Highlights

    VitriVax: one-shot Covid-19 vaccines to improve global access - Pharmaceutical Technology
    VitriVax: one-shot Covid-19 vaccines to improve global access - Pharmaceutical Technology
    Charlie Petty
    Add to my network

    Location

    New York, New York, United States